133 results on '"Merlin, Jean-Louis"'
Search Results
2. Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
3. Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS)
4. CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
5. ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
6. #927 Homologous recombination deficiency determination in patients with high-grade serous ovarian cancer: real-word experience in the french cancer institute of lorraine
7. Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
8. Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
9. Innovations en épidémiologie clinique et biostatistiques 2023 – Bienvenue à Nancy
10. DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
11. Conversational hypnosis versus standard of care to reduce anxiety in patients undergoing marker placement under radiographic control prior to breast cancer surgery: A randomized, multicenter trial
12. CRISPR/Cas9-Mediated Knockdown Of BRCA1/2 Restores Response To Olaparib In Pancreatic Cancer Cell Lines
13. Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
14. Intraoperative prediction of non‑sentinel lymph node metastases in breast cancer using cytokeratin 19 mRNA copy number: A retrospective analysis
15. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
16. Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
17. A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
18. Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
19. Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)
20. Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study
21. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers
22. Targeted PCR vs NGS for molecular diagnostic in solid tumors and liquid biopsies. How to choose in real-life.
23. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
24. Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
25. Identification of Specific Tumor Markers in Vulvar Carcinoma Through Extensive Human Papillomavirus DNA Characterization Using Next Generation Sequencing Method
26. Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas
27. Emerging Roles of DDB2 in Cancer
28. Somatic substitution signature as an innovative tool in lung cancer diagnosis
29. Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation
30. Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
31. Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
32. cfDNA for accurate determination of RAS and BRAF mutations using OncoBEAM liquid biopsy in metastatic colorectal cancer patients: Results of the real-world multicentric ColoBEAM study.
33. Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing
34. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma
35. Technical considerations for circulating tumor DNA detection in oncology
36. Somatic Substitution Signature as an Innovative Tool in Lung Cancer Diagnosis
37. Towards a RAS mutation status in a single day for patients with advanced colorectal cancers. Authors’ reply
38. Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation
39. Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma
40. Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples
41. Clinical Interest of Circulating Tumor DNA in Oncology
42. A Model of Chronic Exposure to Unpredictable Mild Socio-Environmental Stressors Replicates Some Spaceflight-Induced Immunological Changes
43. RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014
44. A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium
45. Abstract 2719: Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma : MELFAST trial
46. Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients
47. New advances in DPYD genotype and risk of severe toxicity under capecitabine
48. Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma
49. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
50. Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.